| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-22 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2002-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afa86b2a8f64c28f195160b919611371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d8360705fba0ca508df7055f4e72d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12b422e28e037538076106c96ec4cbaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_945a341f46a5a955288028cd56249960
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5617b90d2a5aa0fa0994177bcc8fda0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55e91cd20dc5faab2e47efbfc3616813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf24df0fe50ea2e7cea1754a20378157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be95662ecf255145ac7b81bd6ac0645d |
| publicationDate |
2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004265328-A1 |
| titleOfInvention |
Pathogenic and commensal vaccine antigens |
| abstract |
The invention provides methods of screening commensal and pathogenic bacteria for previously unidentified vaccine antigens, based upon identifying polypeptide antigens that bind to sera raised against commensal bacterial proteins. Also provided are vaccine compositions and methods of preparing vaccine compositions comprising the antigens identified by the screening methods. Antigens and uses thereof are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11668021-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018208877-A1 |
| priorityDate |
2001-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |